Benjamin Howard

Benjamin Howard is an experienced professional in business development and strategy within the biotechnology and pharmaceutical sectors. Currently serving as Manager at TScan Therapeutics since July 2022, Benjamin previously held positions as Associate Manager and Business Development Analyst at Promedior, Inc. and as an Analyst at ClearView Healthcare Partners, where significant contributions included developing financial models for rare disease therapies and gene therapy strategies. Early experiences include internships focused on target biology research at Ra Pharmaceuticals and gastrointestinal research at Massachusetts General Hospital. Benjamin holds a Bachelor of Science in Biochemistry and Molecular Biology from Hamilton College and has completed the Business Bridge Program at The Tuck School of Business at Dartmouth, as well as an online certificate in immunology from Harvard Medical School.